<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - 07/24/2024</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Progress note - 07/24/2024</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">PATRICIA LOTT</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">September 9, 1964 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Female</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Black or African American</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Declined to Specify</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>1620 SW 67th AVENUE<br/>North Lauderdale, FL 33068, US<br/><br/>Work Phone:  954-806-3270<br/>Primary Home Phone:  954-806-3270<br/>Mobile Phone:  954-806-3270<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">79752 2.16.840.1.113883.4.391.330529<br/>79752 2.16.840.1.113883.4.391.330529.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">2e125406-2bcd-4f02-981d-222fa7caa466 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">October 11, 2024, 15:30:29 -0400 </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer </span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">JASON HAFFIZULLA</td></tr><tr><td class="td_header_role_value internal_format">7875 W COMMERCIAL BLVD<br/>TAMARAC, FL 33351-4353, US<br/><br/>Tel:  954-726-0099<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">1053344 2.16.840.1.113883.4.391.330529</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">ambulatory</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From July 24, 2024, 09:30:00   to July 24, 2024, 09:45:00  </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">id:  2.16.840.1.113883.4.391.330529</td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">JASON HAFFIZULLA</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">7875 W COMMERCIAL BLVD<br/>TAMARAC, FL 33351-4353, US<br/><br/>Tel:  954-726-0099<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">PATRICIA LOTT<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  954-806-3270<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">JASON HAFFIZULLA signed at July 25, 2024 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">7875 W COMMERCIAL BLVD<br/>TAMARAC, FL 33351-4353, US<br/><br/>Tel:  954-726-0099<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">Medical Associates Of Tamarac Pa</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">7875 W COMMERCIAL BLVD<br/>TAMARAC, FL 33351-4353, US<br/><br/>Tel:  954-726-0099<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">ALLERGIES</a></li><li><a href="#id2">RESULTS</a></li><li><a href="#id3">REASON FOR VISIT</a></li><li><a href="#id4">MEDICATIONS</a></li><li><a href="#id5">PROBLEMS</a></li><li><a href="#id6">VITAL SIGNS</a></li><li><a href="#id7">Encounters</a></li><li><a href="#id8">ASSESSMENTS</a></li><li><a href="#id9">PLAN OF TREATMENT</a></li><li><a href="#id10">Progress Notes</a></li><li><a href="#id11">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">ALLERGIES</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1">morphine</td><td>Morphine</td><td ID="reaction1">Unknown</td><td>Drug Allergy</td><td>09/23/2016</td><td>Active</td></tr><tr><td ID="allergy2">Substance with penicillin structure and antibacterial mechanism of action (substance)</td><td>Penicillins</td><td ID="reaction2">Unknown</td><td>Drug Allergy</td><td>12/19/2014</td><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">RESULTS</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">LIPID PANEL, STANDARD (7600)</span><br/>Reviewed date:07/27/2024 11:06:11 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami10200 Commerce Pkwy, MiramarFL33025-3938 DR. Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result1_attr1">CHOLESTEROL, TOTAL</td><td>208</td><td>&lt;200 mg/dL</td><td/></tr><tr><td ID="result1_attr2">HDL CHOLESTEROL</td><td>47</td><td>&gt; OR = 50 mg/dL</td><td/></tr><tr><td ID="result1_attr3">TRIGLYCERIDES</td><td>190</td><td>&lt;150 mg/dL</td><td/></tr><tr><td ID="result1_attr4">LDL-CHOLESTEROL</td><td>128</td><td/><td ID="result1_attr4_notes"><p>Reference range: &lt;100</p><p>Desirable range &lt;100 mg/dL for primary prevention;</p><p>&lt;70 mg/dL for patients with CHD or diabetic patients</p><p>with &gt; or = 2 CHD risk factors.</p><p>LDL-C is now calculated using the Martin-Hopkins</p><p>calculation, which is a validated novel method providing</p><p>better accuracy than the Friedewald equation in the</p><p>estimation of LDL-C.</p><p>Martin SS et al. JAMA. 2013;310(19): 2061-2068</p><p>(http://education.QuestDiagnostics.com/faq/FAQ164)</p></td></tr><tr><td ID="result1_attr5">CHOL/HDLC RATIO</td><td>4.4</td><td>&lt;5.0 (calc)</td><td/></tr><tr><td ID="result1_attr6">NON HDL CHOLESTEROL</td><td>161</td><td>&lt;130 mg/dL (calc)</td><td ID="result1_attr6_notes"><p>For patients with diabetes plus 1 major ASCVD risk</p><p>factor, treating to a non-HDL-C goal of &lt;100 mg/dL</p><p>(LDL-C of &lt;70 mg/dL) is considered a therapeutic</p><p>option.</p></td></tr><tr><td colspan="4"><span class="content_span">COMPREHENSIVE METABOLIC PANEL (10231)</span><br/>Reviewed date:07/27/2024 11:06:11 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami10200 Commerce Pkwy, MiramarFL33025-3938 DR. Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result2_attr1">GLUCOSE</td><td>93</td><td>65-99 mg/dL</td><td ID="result2_attr1_notes"><p/><p>           Fasting reference interval</p></td></tr><tr><td ID="result2_attr2">UREA NITROGEN (BUN)</td><td>18</td><td>7-25 mg/dL</td><td/></tr><tr><td ID="result2_attr3">CREATININE</td><td>1.26</td><td>0.50-1.03 mg/dL</td><td/></tr><tr><td ID="result2_attr4">EGFR</td><td>49</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/></tr><tr><td ID="result2_attr5">BUN/CREATININE RATIO</td><td>14</td><td>6-22 (calc)</td><td/></tr><tr><td ID="result2_attr6">SODIUM</td><td>140</td><td>135-146 mmol/L</td><td/></tr><tr><td ID="result2_attr7">POTASSIUM</td><td>4.6</td><td>3.5-5.3 mmol/L</td><td/></tr><tr><td ID="result2_attr8">CHLORIDE</td><td>99</td><td>98-110 mmol/L</td><td/></tr><tr><td ID="result2_attr9">CARBON DIOXIDE</td><td>26</td><td>20-32 mmol/L</td><td/></tr><tr><td ID="result2_attr10">CALCIUM</td><td>9.7</td><td>8.6-10.4 mg/dL</td><td/></tr><tr><td ID="result2_attr11">PROTEIN, TOTAL</td><td>7.8</td><td>6.1-8.1 g/dL</td><td/></tr><tr><td ID="result2_attr12">ALBUMIN</td><td>4.2</td><td>3.6-5.1 g/dL</td><td/></tr><tr><td ID="result2_attr13">GLOBULIN</td><td>3.6</td><td>1.9-3.7 g/dL (calc)</td><td/></tr><tr><td ID="result2_attr14">ALBUMIN/GLOBULIN RATIO</td><td>1.2</td><td>1.0-2.5 (calc)</td><td/></tr><tr><td ID="result2_attr15">BILIRUBIN, TOTAL</td><td>0.6</td><td>0.2-1.2 mg/dL</td><td/></tr><tr><td ID="result2_attr16">ALKALINE PHOSPHATASE</td><td>66</td><td>37-153 U/L</td><td/></tr><tr><td ID="result2_attr17">AST</td><td>12</td><td>10-35 U/L</td><td/></tr><tr><td ID="result2_attr18">ALT</td><td>15</td><td>6-29 U/L</td><td/></tr><tr><td colspan="4"><span class="content_span">CBC (INCLUDES DIFF/PLT) (6399)</span><br/>Reviewed date:07/27/2024 11:06:11 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami10200 Commerce Pkwy, MiramarFL33025-3938 DR. Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result3_attr1">WHITE BLOOD CELL COUNT</td><td>5.7</td><td>3.8-10.8 Thousand/uL</td><td/></tr><tr><td ID="result3_attr2">RED BLOOD CELL COUNT</td><td>4.19</td><td>3.80-5.10 Million/uL</td><td/></tr><tr><td ID="result3_attr3">HEMOGLOBIN</td><td>12.0</td><td>11.7-15.5 g/dL</td><td/></tr><tr><td ID="result3_attr4">HEMATOCRIT</td><td>37.1</td><td>35.0-45.0 %</td><td/></tr><tr><td ID="result3_attr5">MCV</td><td>88.5</td><td>80.0-100.0 fL</td><td/></tr><tr><td ID="result3_attr6">MCH</td><td>28.6</td><td>27.0-33.0 pg</td><td/></tr><tr><td ID="result3_attr7">MCHC</td><td>32.3</td><td>32.0-36.0 g/dL</td><td/></tr><tr><td ID="result3_attr8">RDW</td><td>13.3</td><td>11.0-15.0 %</td><td/></tr><tr><td ID="result3_attr9">PLATELET COUNT</td><td>226</td><td>140-400 Thousand/uL</td><td/></tr><tr><td ID="result3_attr10">MPV</td><td>10.0</td><td>7.5-12.5 fL</td><td/></tr><tr><td ID="result3_attr11">ABSOLUTE NEUTROPHILS</td><td>3181</td><td>1500-7800 cells/uL</td><td/></tr><tr><td ID="result3_attr12">ABSOLUTE LYMPHOCYTES</td><td>1858</td><td>850-3900 cells/uL</td><td/></tr><tr><td ID="result3_attr13">ABSOLUTE MONOCYTES</td><td>564</td><td>200-950 cells/uL</td><td/></tr><tr><td ID="result3_attr14">ABSOLUTE EOSINOPHILS</td><td>68</td><td>15-500 cells/uL</td><td/></tr><tr><td ID="result3_attr15">ABSOLUTE BASOPHILS</td><td>29</td><td>0-200 cells/uL</td><td/></tr><tr><td ID="result3_attr16">NEUTROPHILS</td><td>55.8</td><td/><td/></tr><tr><td ID="result3_attr17">LYMPHOCYTES</td><td>32.6</td><td/><td/></tr><tr><td ID="result3_attr18">MONOCYTES</td><td>9.9</td><td/><td/></tr><tr><td ID="result3_attr19">EOSINOPHILS</td><td>1.2</td><td/><td/></tr><tr><td ID="result3_attr20">BASOPHILS</td><td>0.5</td><td/><td/></tr><tr><td colspan="4"><span class="content_span">HEMOGLOBIN A1c (496)</span><br/>Reviewed date:07/27/2024 11:06:11 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami10200 Commerce Pkwy, MiramarFL33025-3938 DR. Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result4_attr1">HEMOGLOBIN A1c</td><td>6.6</td><td>&lt;5.7 % of total Hgb</td><td ID="result4_attr1_notes"><p>For someone without known diabetes, a hemoglobin A1c</p><p>value of 6.5% or greater indicates that they may have</p><p>diabetes and this should be confirmed with a follow-up</p><p>test.</p><p>For someone with known diabetes, a value &lt;7% indicates</p><p>that their diabetes is well controlled and a value</p><p>greater than or equal to 7% indicates suboptimal</p><p>control. A1c targets should be individualized based on</p><p>duration of diabetes, age, comorbid conditions, and</p><p>other considerations.</p><p>Currently, no consensus exists regarding use of</p><p>hemoglobin A1c for diagnosis of diabetes for children.</p><p>This test was performed on the Roche cobas c503 platform.</p><p>Effective 10/16/23, a change in test platforms from the</p><p>Abbott Architect to the Roche cobas c503 may have shifted</p><p>HbA1c results compared to historical results.</p><p>Based on laboratory validation testing conducted at</p><p>Quest, the Roche platform relative to the Abbott</p><p>platform had an average increase in HbA1c value of</p><p>&lt; or = 0.3%. This difference is within accepted</p><p>variability established by the National Glycohemoglobin</p><p>Standardization Program. Note that not all individuals</p><p>will have had a shift in their results and direct</p><p>comparisons between historical and current results for</p><p>testing conducted on different platforms is not</p><p>recommended.</p></td></tr><tr><td colspan="4"><span class="content_span">TSH (899)</span><br/>Reviewed date:07/27/2024 11:06:11 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami10200 Commerce Pkwy, MiramarFL33025-3938 DR. Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING<br/>NON-FASTING NON-FASTING NON-FASTING NON-FASTING</td></tr><tr><td ID="result5_attr1">TSH</td><td>2.25</td><td>0.40-4.50 mIU/L</td><td/></tr><tr><td colspan="4"><span class="content_span">PTH, INTACT WITHOUT CALCIUM (35202)</span><br/>Reviewed date:07/27/2024 11:06:11 AM<br/>Interpretation:<br/>Performing Lab:MI, Quest Diagnostics-Miami10200 Commerce Pkwy, MiramarFL33025-3938 DR. Julie L Friedman<br/>Notes/Report:<br/>NON-FASTING</td></tr><tr><td ID="result6_attr1">PARATHYROID HORMONE, INTACT</td><td>75</td><td>16-77 pg/mL</td><td ID="result6_attr1_notes"><p/><p>Interpretive Guide    Intact PTH           Calcium</p><p>------------------    ----------           -------</p><p>Normal Parathyroid    Normal               Normal</p><p>Hypoparathyroidism    Low or Low Normal    Low</p><p>Hyperparathyroidism</p><p>   Primary            Normal or High       High</p><p>   Secondary          High                 Normal or Low</p><p>   Tertiary           High                 High</p><p>Non-Parathyroid</p><p>   Hypercalcemia      Low or Low Normal    High</p></td></tr></tbody></table></div><h3><a name="id3" href="#toc">REASON FOR VISIT</a></h3><div>F/u</div><h3><a name="id4" href="#toc">MEDICATIONS</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Triamcinolone Acetonide 0.1 %</td><td ID="instruction1">1 application Externally twice per dy for 30 days</td><td/><td>07/24/2024</td><td/><td>Active</td></tr><tr><td ID="medication2">Zolpidem Tartrate 10 MG</td><td ID="instruction2">1 tablet at bedtime as needed Orally Once a day for 90 days</td><td/><td>07/24/2024</td><td/><td>Active</td></tr><tr><td ID="medication3">Triamterene-HCTZ 37.5-25 MG</td><td ID="instruction3">1 tablet in the morning Oral Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">diazePAM 10 MG</td><td ID="instruction4">1 tablet as needed Orally Once a day for 90 days</td><td/><td>07/24/2024</td><td/><td>Active</td></tr><tr><td ID="medication5">Amitriptyline HCl 100 MG</td><td ID="instruction5">TAKE 1 TABLET BY MOUTH EVERY DAY AT BEDTIME for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Omeprazole 40 MG</td><td ID="instruction6">TAKE 1 CAPSULE BY MOUTH EVERY DAY 30 MINUTES BEFORE BREAKFAST for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">ARIPiprazole 5 MG</td><td ID="instruction7">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">traMADol HCl 50 MG</td><td ID="instruction8">1 tablet as needed Orally Once a day for 30 days</td><td/><td>07/24/2024</td><td/><td>Active</td></tr><tr><td ID="medication9">Clarithromycin 500 MG</td><td ID="instruction9">1 tablet oral every 12 hrs for 10 day(s)</td><td/><td>02/01/2024</td><td/><td>Not-Taking</td></tr><tr><td ID="medication10">oxyCODONE-Acetaminophen 7.5-325 MG</td><td ID="instruction10">TAKE 1 TABLET BY MOUTH EVERY 8 HOURS AS NEEDED Oral for 30 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">Ipratropium-Albuterol 0.5-2.5 (3) MG/3ML</td><td ID="instruction11">One jet neb to nebulizer QID Inhalation for 90 days</td><td ID="medication11notes">**$IMPORTANT- Apply Patient Savings Program: BIN:610378, PCN:SC1, Group:615482, ID#003123621, Submit as primary insurance to SingleCare adjudicator. Questions: 800.974.3135albuterol-ipratropium</td><td>02/19/2018</td><td/><td>Active</td></tr><tr><td ID="medication12">Furosemide 40 MG</td><td ID="instruction12">TAKE 1 TABLET BY MOUTH EVERY DAY Oral for 90 days</td><td ID="medication12notes">furosemide</td><td>04/28/2023</td><td/><td>Active</td></tr><tr><td ID="medication13">Rosuvastatin Calcium 5 MG</td><td ID="instruction13">1 tablet Orally Once a day for 90 day(s)</td><td/><td>07/09/2023</td><td/><td>Active</td></tr><tr><td ID="medication14">Clotrimazole-Betamethasone 1-0.05 %</td><td ID="instruction14">APPLY TO THE AFFECTED AREA TWICE DAILY for 60</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication15">Cymbalta 60 MG</td><td ID="instruction15">1 capsule Orally twice a day for 90 days</td><td/><td>07/07/2023</td><td/><td>Active</td></tr><tr><td ID="medication16">sulfaSALAzine 500 MG</td><td ID="instruction16">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication17">Symbicort 160-4.5 MCG/ACT</td><td ID="instruction17">2 puffs Inhalation Twice a day</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">PROBLEMS</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>SNOMED Code</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td ID="Problem1">Hyperparathyroidism, secondary renal (N25.81)</td><td/><td>Active</td><td>confirmed</td><td/><td>Hyperparathyroidism due to renal insufficiency (19034001)</td><td/></tr><tr><td>Problem</td><td ID="Problem2">Secondary hyperparathyroidism of renal origin (N25.81)</td><td/><td>Active</td><td>confirmed</td><td/><td>Secondary hyperparathyroidism of renal origin (19034001)</td><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">VITAL SIGNS</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Temperature</th><td>97.9 degrees Fahrenheit</td><td>07/24/2024</td></tr><tr><th ID="vital2">Blood pressure systolic</th><td>128 mm Hg</td><td>07/24/2024</td></tr><tr><th ID="vital3">Blood pressure diastolic</th><td>82 mm Hg</td><td>07/24/2024</td></tr><tr><th ID="vital4">Heart Rate</th><td>84 /min</td><td>07/24/2024</td></tr><tr><th ID="vital5">Height</th><td>67 in</td><td>07/24/2024</td></tr><tr><th ID="vital6">Weight</th><td>252.6 lbs</td><td>07/24/2024</td></tr><tr><th ID="vital7">BMI</th><td>39.56 kg/m2</td><td>07/24/2024</td></tr><tr><th ID="vital8">Height-cm</th><td>170.18 cm</td><td>07/24/2024</td></tr><tr><th ID="vital9">Weight-kg</th><td>114.58 kg</td><td>07/24/2024</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>Medical Associates Of Tamarac Pa</td><td>7875 W COMMERCIAL BLVD TAMARAC, FL 33351-4353</td><td>07/24/2024</td><td>JASON HAFFIZULLA</td><td>Chronic kidney disease, stage 3a N18.31 ; Morbid (severe) obesity due to excess calories E66.01 ; Sedative, hypnotic or anxiolytic dependence, uncomplicated F13.20 ; Opioid dependence, uncomplicated F11.20 ; Chronic obstructive pulmonary disease, unspecified J44.9 ; Rheumatoid arthritis, unspecified M06.9 ; Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene E11.51 ; Bipolar 1 disorder, depressed, severe F31.4 ; Immunodeficiency due to drugs D84.821 ; Sacroiliitis, not elsewhere classified M46.1 ; Supraventricular tachycardia, unspecified I47.10 ; Severe persistent asthma, uncomplicated J45.50 ; Monoplegia of lower limb following cerebral infarction affecting right non-dominant side I69.343 ; Chronic diastolic (congestive) heart failure I50.32 ; Secondary hyperparathyroidism of renal origin N25.81 and Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.0</td></tr></tbody></table></div><h3><a name="id8" href="#toc">ASSESSMENTS</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">07/24/2024</td><td>Chronic kidney disease, stage 3a (ICD-10 - N18.31)</td><td/><td>controlled on increased fluid intake</td><td/></tr><tr><td ID="ref2">07/24/2024</td><td>Morbid (severe) obesity due to excess calories (ICD-10 - E66.01)</td><td>Mig-1624898-</td><td>controlled on low fat diet and comorbid with depression and RA</td><td/></tr><tr><td ID="ref3">07/24/2024</td><td>Sedative, hypnotic or anxiolytic dependence, uncomplicated (ICD-10 - F13.20)</td><td>Mig-1624898-</td><td>Diazepam for anxiety.  Pt noted to be dependent on diazepam. unable to wean without return of symptoms. has shown drug seeking behavior for sedative. has shown desire to increase dose of sedative beyond recommended despite recommendation to stay at current dose. has been annoyed by doctor, medical personnel and family to decrease or stop use of sedative.  </td><td/></tr><tr><td ID="ref4">07/24/2024</td><td>Opioid dependence, uncomplicated (ICD-10 - F11.20)</td><td>Mig-1624898-</td><td>patient using oxycodone for chronic pain and anxiety .pt has shown dependence on codeine syrup. has failed to wean from opiate despite attempts to in the past. has shown drug seeking behavior for opiate and has been annoyed by doctors/medical personnel and family to decrease or stop dependence on opiate. has increased use of opiate beyond recommended dose given by medical personnel </td><td/></tr><tr><td ID="ref5">07/24/2024</td><td>Chronic obstructive pulmonary disease, unspecified (ICD-10 - J44.9)</td><td>Mig-1624898-</td><td>controlled on    Ipratropium-Albuterol</td><td/></tr><tr><td ID="ref6">07/24/2024</td><td>Rheumatoid arthritis, unspecified (ICD-10 - M06.9)</td><td>Mig-1624898-</td><td>controlled on sulfasalazine</td><td/></tr><tr><td ID="ref7">07/24/2024</td><td>Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene (ICD-10 - E11.51)</td><td>Mig-1624898-</td><td>dm cotnrolled on lowcarb diet and unable to take dm meds due to hypoglycemia since weight loss after son died and pad due to dm controlle donincreased walking eercises</td><td/></tr><tr><td ID="ref8">07/24/2024</td><td>Bipolar 1 disorder, depressed, severe (ICD-10 - F31.4)</td><td/><td>not controlled on cymbalta and amitryptilline. add abilify and refer to dr latif for psych</td><td/></tr><tr><td ID="ref9">07/24/2024</td><td>Immunodeficiency due to drugs (ICD-10 - D84.821)</td><td/><td>due to chronic sulfasalazine for rheumatoid arthritis. contoleld on mask wearing and vaccination every 6 months </td><td/></tr><tr><td ID="ref10">07/24/2024</td><td>Sacroiliitis, not elsewhere classified (ICD-10 - M46.1)</td><td>Mig-1624898-</td><td>xray visible inflammation. tender in the right costal and si joint area, treated with sulfasalazine and NSAIDs PRN. </td><td/></tr><tr><td ID="ref11">07/24/2024</td><td>Supraventricular tachycardia, unspecified (ICD-10 - I47.10)</td><td/><td>controlled on maxzide</td><td/></tr><tr><td ID="ref12">07/24/2024</td><td>Severe persistent asthma, uncomplicated (ICD-10 - J45.50)</td><td/><td>controlled on symbicort</td><td/></tr><tr><td ID="ref13">07/24/2024</td><td>Monoplegia of lower limb following cerebral infarction affecting right non-dominant side (ICD-10 - I69.343)</td><td/><td>controlled on walking exercises</td><td/></tr><tr><td ID="ref14">07/24/2024</td><td>Chronic diastolic (congestive) heart failure (ICD-10 - I50.32)</td><td/><td>controlle don maxzide</td><td/></tr><tr><td ID="ref15">07/24/2024</td><td>Secondary hyperparathyroidism of renal origin (ICD-10 - N25.81)</td><td/><td>controlled on increased fluid intake</td><td/></tr><tr><td ID="ref16">07/24/2024</td><td>Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I13.0)</td><td/><td>htn controlled on maxzide and chf and ckd due to htn controlled on maxzide and increased fluid intake</td><td/></tr><tr><td ID="ref17">07/24/2024</td><td>Other</td><td/><td>controlled on cymbalta and amitryptilline.      managed with  Triamterene-HCTZ  managed RA with sulfasalazine  controlle don increased flud intake</td><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">PLAN OF TREATMENT</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Triamcinolone Acetonide 0.1 %</td><td>1 application Externally twice per dy for 30 days</td><td>07/24/2024</td><td/><td/></tr><tr><td ID="potMeds2">Zolpidem Tartrate 10 MG</td><td>1 tablet at bedtime as needed Orally Once a day for 90 days</td><td>07/24/2024</td><td/><td/></tr><tr><td ID="potMeds3">diazePAM 10 MG</td><td>1 tablet as needed Orally Once a day for 90 days</td><td>07/24/2024</td><td/><td/></tr><tr><td ID="potMeds4">ARIPiprazole 5 MG</td><td>1 tablet Orally Once a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds5">traMADol HCl 50 MG</td><td>1 tablet as needed Orally Once a day for 30 days</td><td>07/24/2024</td><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Chronic kidney disease, stage 3a</td><td>controlled on increased fluid intake</td></tr><tr><td ID="instructionpot2">Morbid (severe) obesity due to excess calories</td><td>controlled on low fat diet and comorbid with depression and RA</td></tr><tr><td ID="instructionpot3">Sedative, hypnotic or anxiolytic dependence, uncomplicated</td><td>Diazepam for anxiety.  Pt noted to be dependent on diazepam. unable to wean without return of symptoms. has shown drug seeking behavior for sedative. has shown desire to increase dose of sedative beyond recommended despite recommendation to stay at current dose. has been annoyed by doctor, medical personnel and family to decrease or stop use of sedative.  </td></tr><tr><td ID="instructionpot4">Opioid dependence, uncomplicated</td><td>patient using oxycodone for chronic pain and anxiety .pt has shown dependence on codeine syrup. has failed to wean from opiate despite attempts to in the past. has shown drug seeking behavior for opiate and has been annoyed by doctors/medical personnel and family to decrease or stop dependence on opiate. has increased use of opiate beyond recommended dose given by medical personnel </td></tr><tr><td ID="instructionpot5">Chronic obstructive pulmonary disease, unspecified</td><td>controlled on    Ipratropium-Albuterol</td></tr><tr><td ID="instructionpot6">Rheumatoid arthritis, unspecified</td><td>controlled on sulfasalazine</td></tr><tr><td ID="instructionpot7">Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene</td><td>dm cotnrolled on lowcarb diet and unable to take dm meds due to hypoglycemia since weight loss after son died and pad due to dm controlle donincreased walking eercises</td></tr><tr><td ID="instructionpot8">Bipolar 1 disorder, depressed, severe</td><td>not controlled on cymbalta and amitryptilline. add abilify and refer to dr latif for psych</td></tr><tr><td ID="instructionpot9">Immunodeficiency due to drugs</td><td>due to chronic sulfasalazine for rheumatoid arthritis. contoleld on mask wearing and vaccination every 6 months </td></tr><tr><td ID="instructionpot10">Sacroiliitis, not elsewhere classified</td><td>xray visible inflammation. tender in the right costal and si joint area, treated with sulfasalazine and NSAIDs PRN. </td></tr><tr><td ID="instructionpot11">Supraventricular tachycardia, unspecified</td><td>controlled on maxzide</td></tr><tr><td ID="instructionpot12">Severe persistent asthma, uncomplicated</td><td>controlled on symbicort</td></tr><tr><td ID="instructionpot13">Monoplegia of lower limb following cerebral infarction affecting right non-dominant side</td><td>controlled on walking exercises</td></tr><tr><td ID="instructionpot14">Chronic diastolic (congestive) heart failure</td><td>controlle don maxzide</td></tr><tr><td ID="instructionpot15">Secondary hyperparathyroidism of renal origin</td><td>controlled on increased fluid intake</td></tr><tr><td ID="instructionpot16">Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</td><td>htn controlled on maxzide and chf and ckd due to htn controlled on maxzide and increased fluid intake</td></tr><tr><td ID="instructionpot17">Other</td><td>controlled on cymbalta and amitryptilline.      managed with  Triamterene-HCTZ  managed RA with sulfasalazine  controlle don increased flud intake</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 2 Months, Reason: </td></tr><tr><td ID="futureAppt1">Provider Name:JASON M HAFFIZULLA, 10/30/2024 09:15:00 AM, 7875 W COMMERCIAL BLVD, TAMARAC, FL, 33351-4353, 954-726-0099</td></tr></tbody></table></div><h3><a name="id10" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>LOTT, PATRICIA <span class="bold">DOB:</span> 09/09/1964 (59 yo F) <span class="bold">Acc No.</span> 79752 <span class="bold">DOS:</span> 07/24/2024</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">Progress Notes</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>LOTT, PATRICIA<br/><span class="bold">Account Number: </span>79752</td><td align="right"><span class="bold">Provider: </span>Jason Haffizulla, MD</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>09/09/1964<span class="bold">   Age: </span>59 Y<span class="bold">   Sex: </span>Female</td><td align="right"><span class="bold">Date: </span>07/24/2024</td></tr><tr><td><span class="bold">Phone: </span>954-806-3270</td></tr><tr><td colspan="2"><span class="bold">Address: </span>1620 SW 67th AVENUE, North Lauderdale, FL-33068</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   1. F/u. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">general</span>: <br/>       check up from hospital visit for leg pain.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">Allergy / Immunology</span>: <br/>      Patient denies hives,  itching,  rash.   <br/>   <span class="Underline">Ophthalmologic</span>: <br/>      Patient denies blurry vision,  discharge,  red eye(s).   <br/>   <span class="Underline">Endocrine</span>: <br/>      Patient denies cold intolerance,  hair loss,  irregular menses.   <br/>   <span class="Underline">Respiratory</span>: <br/>      Patient denies chronic cough,  shortness of breath,  sputum production.   <br/>   <span class="Underline">Breast</span>: <br/>      Patient denies bloody nipple discharge,  breast pain,  breast swelling.   <br/>   <span class="Underline">Cardiovascular</span>: <br/>      Patient denies chest pain,  chest pain with exertion,  irregular heartbeat.   <br/>   <span class="Underline">Gastrointestinal</span>: <br/>      Patient denies abdominal pain,  diarrhea,  rectal bleeding.   <br/>   <span class="Underline">Hematology</span>: <br/>      Patient denies easy bleeding,  easy bruising,  recent transfusion.   <br/>   <span class="Underline">Gynecology</span>: <br/>      Patient denies abnormal bleeding,  hot flashes,  pelvic pain.   <br/>   <span class="Underline">Genitourinary</span>: <br/>      Patient denies abdominal pain / swelling,  blood in the urine,  frequent urination.   <br/>   <span class="Underline">Musculoskeletal</span>: <br/>      Patient denies arthritis / arthralgia,  joint stiffness,  swollen joints.   <br/>   <span class="Underline">Peripheral Vascular</span>: <br/>      Patient denies blanching of skin,  cold extremities,  decreased sensation in extremities.   <br/>   <span class="Underline">Podiatric</span>: <br/>      Patient denies ankle pain,  foot pain,  sole pain.   <br/>   <span class="Underline">Skin</span>: <br/>      Patient denies blistering of skin,  changing moles,  skin lesion(s).   <br/>   <span class="Underline">Neurologic</span>: <br/>      Patient denies dizziness,  gait abnormality,  headache.   <br/>   <span class="Underline">Psychiatric</span>: <br/>      Patient denies delusions,  depressed mood,  difficulty sleeping.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> Encounter for examination of eyes and vision without abnormal findings :- Provider/Facility: Dr. Balmary Vazquez 954-720-9201 , Date: 11-09-2021 , , Colonoscopy :- Date: 12-14-2022 , Treatment: FIT TEST IS NEGATIVE  , , Bone density scan :- Notes: Normal bone density  , Provider/Facility: Akumin , Date: 09-21-2021 , , Mammography :- Provider/Facility: florida mobile mammography , Date: 03-04-2023 ,.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="Underline">Migrated Social History:</span> <br/>       Migrated Social History: Negative for: Past drug use , Negative for: Alcohol use , Negative for: Current drug user , Never smoked. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> Taking sulfaSALAzine 500 MG Tablet 1 tablet Orally Once a day , Taking Symbicort 160-4.5 MCG/ACT Aerosol 2 puffs Inhalation Twice a day , Taking Clotrimazole-Betamethasone 1-0.05 % Cream APPLY TO THE AFFECTED AREA TWICE DAILY   , Taking Cymbalta 60 MG Capsule Delayed Release Particles 1 capsule Orally twice a day , Taking Ipratropium-Albuterol 0.5-2.5 (3) MG/3ML Solution One jet neb to nebulizer QID Inhalation  , Notes to Pharmacist: **$IMPORTANT- Apply Patient Savings Program: BIN:610378, PCN:SC1, Group:615482, ID#003123621, Submit as primary insurance to SingleCare adjudicator. Questions: 800.974.3135albuterol-ipratropium, Taking Furosemide 40 MG Tablet TAKE 1 TABLET BY MOUTH EVERY DAY Oral  , Notes to Pharmacist: furosemide, Taking Rosuvastatin Calcium 5 MG Tablet 1 tablet Orally Once a day , Taking Omeprazole 40 MG Capsule Delayed Release TAKE 1 CAPSULE BY MOUTH EVERY DAY 30 MINUTES BEFORE BREAKFAST   , Taking oxyCODONE-Acetaminophen 7.5-325 MG Tablet TAKE 1 TABLET BY MOUTH EVERY 8 HOURS AS NEEDED Oral  , Taking Triamterene-HCTZ 37.5-25 MG Tablet 1 tablet in the morning Oral Once a day , Taking Amitriptyline HCl 100 MG Tablet TAKE 1 TABLET BY MOUTH EVERY DAY AT BEDTIME   , Taking Zolpidem Tartrate 10 MG Tablet TAKE 1 TABLET BY MOUTH EVERY DAY AT BEDTIME AS NEEDED   , Taking diazePAM 10 MG Tablet 1 tablet as needed Orally Once a day , Taking ARIPiprazole 5 MG Tablet 1 tablet Orally Once a day , Taking traMADol HCl 50 MG Tablet 1 tablet as needed Orally Once a day , Not-Taking Clarithromycin 500 MG Tablet 1 tablet oral every 12 hrs , Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> Morphine: Allergy - Onset Date 09/23/2016, Penicillins: Allergy - Onset Date 12/19/2014. </td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> BP: <span class="bold">128/82</span> mm Hg, HR: <span class="bold">84</span> /min, Temp: <span class="bold">97.9</span> F, Wt: <span class="bold">252.6</span> lbs, Wt-kg: 114.58 kg, Ht: 67 in, Ht-cm: 170.18 cm, BMI: <span class="bold">39.56</span> Index, Body Surface Area: 2.32.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      General appearance: morbid obesity. <br/>      Head: normocephalic, atraumatic. <br/>      Ears: normal. <br/>      Oral cavity: normal, with good dentition. <br/>      Throat: clear, no erythema. <br/>      Neck / thyroid: carotid pulses are normal and without bruits, neck is supple, with full range of motion and no cervical lymphadenopathy. <br/>      Lymph nodes: no axillary, supraclavicular or inguinal lymphadenopathy. <br/>      Skin: skin is warm and dry, with no rashes, good skin turgor and normal hair distribution. <br/>      Heart: regular rate and rhythm without murmurs, gallops, clicks or rubs, S1 and S2 are normal and no S3 and S4 gallop. <br/>      Lungs: clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes. <br/>      Chest: chest wall with no costochondral junction tenderness, no rib deformity and normal shape and expansion. <br/>      Abdomen: tender in the right costal margin with abdominal hernia. <br/>      Musculoskeletal: monoplegia right lower extremity due to CVA, r si joint pain. <br/>      Peripheral pulses: decreased BLE pulses. <br/>      Neurologic: nonfocal, alert and oriented, depressed bipolar deep tendon reflexes, right sided monoplegia of lower limb due to CVA.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Chronic kidney disease, stage 3a - N18.31 2. Morbid (severe) obesity due to excess calories - E66.01, Mig-1624898- 3. Sedative, hypnotic or anxiolytic dependence, uncomplicated - F13.20, Mig-1624898- 4. Opioid dependence, uncomplicated - F11.20, Mig-1624898- 5. Chronic obstructive pulmonary disease, unspecified - J44.9, Mig-1624898- 6. Rheumatoid arthritis, unspecified - M06.9, Mig-1624898- 7. Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene - E11.51, Mig-1624898- 8. Bipolar 1 disorder, depressed, severe - F31.4 9. Immunodeficiency due to drugs - D84.821 10. Sacroiliitis, not elsewhere classified - M46.1, Mig-1624898- 11. Supraventricular tachycardia, unspecified - I47.10 12. Severe persistent asthma, uncomplicated - J45.50 13. Monoplegia of lower limb following cerebral infarction affecting right non-dominant side - I69.343 14. Chronic diastolic (congestive) heart failure - I50.32 15. Secondary hyperparathyroidism of renal origin - N25.81 16. Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease - I13.0 </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Chronic kidney disease, stage 3a</span> <br/>Notes: controlled on increased fluid intake  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Morbid (severe) obesity due to excess calories</span> <br/>     <span class="Underline">LAB: LIPID PANEL, STANDARD (7600) (Collection Date &amp; Time - 07/24/2024 12:40 PM)</span><ul><li><table width="100%" border="0"><tbody><tr><td align="left">          <span class="Underline"/></td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">     </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">     TRIGLYCERIDES</td><td align="left">190</td><td align="left">H</td><td align="left">&lt;150 - mg/dL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     CHOLESTEROL, TOTAL</td><td align="left">208</td><td align="left">H</td><td align="left">&lt;200 - mg/dL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     HDL CHOLESTEROL</td><td align="left">47</td><td align="left">L</td><td align="left">&gt; OR = 50 - mg/dL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     LDL-CHOLESTEROL</td><td align="left">128</td><td align="left">H</td><td align="left"> - mg/dL (calc)</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     CHOL/HDLC RATIO</td><td align="left">4.4</td><td align="left"/><td align="left">&lt;5.0 - (calc)</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     NON HDL CHOLESTEROL</td><td align="left">161</td><td align="left">H</td><td align="left">&lt;130 - mg/dL (calc)</td></tr></tbody></table></li></ul>     <span class="Underline">LAB: HEMOGLOBIN A1c (496) (Collection Date &amp; Time - 07/24/2024 12:40 PM)</span><ul><li><table width="100%" border="0"><tbody><tr><td align="left">          <span class="Underline"/></td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">     </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">     HEMOGLOBIN A1c</td><td align="left">6.6</td><td align="left">H</td><td align="left">&lt;5.7 - % of total Hgb</td></tr></tbody></table></li></ul>     <span class="Underline">LAB: TSH (899) (Collection Date &amp; Time - 07/24/2024 12:40 PM)</span><ul><li><table width="100%" border="0"><tbody><tr><td align="left">          <span class="Underline"/></td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">     </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">     TSH</td><td align="left">2.25</td><td align="left"/><td align="left">0.40-4.50 - mIU/L</td></tr></tbody></table></li></ul>     <span class="Underline">LAB: CBC (INCLUDES DIFF/PLT) (6399) (Collection Date &amp; Time - 07/24/2024 12:40 PM)</span><ul><li><table width="100%" border="0"><tbody><tr><td align="left">          <span class="Underline"/></td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">     </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">     WHITE BLOOD CELL COUNT</td><td align="left">5.7</td><td align="left"/><td align="left">3.8-10.8 - Thousand/uL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     RED BLOOD CELL COUNT</td><td align="left">4.19</td><td align="left"/><td align="left">3.80-5.10 - Million/uL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     HEMOGLOBIN</td><td align="left">12.0</td><td align="left"/><td align="left">11.7-15.5 - g/dL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     HEMATOCRIT</td><td align="left">37.1</td><td align="left"/><td align="left">35.0-45.0 - %</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     MCV</td><td align="left">88.5</td><td align="left"/><td align="left">80.0-100.0 - fL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     MCH</td><td align="left">28.6</td><td align="left"/><td align="left">27.0-33.0 - pg</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     MCHC</td><td align="left">32.3</td><td align="left"/><td align="left">32.0-36.0 - g/dL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     RDW</td><td align="left">13.3</td><td align="left"/><td align="left">11.0-15.0 - %</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     PLATELET COUNT</td><td align="left">226</td><td align="left"/><td align="left">140-400 - Thousand/uL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     NEUTROPHILS</td><td align="left">55.8</td><td align="left"/><td align="left"> - %</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     ABSOLUTE NEUTROPHILS</td><td align="left">3181</td><td align="left"/><td align="left">1500-7800 - cells/uL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     LYMPHOCYTES</td><td align="left">32.6</td><td align="left"/><td align="left"> - %</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     ABSOLUTE LYMPHOCYTES</td><td align="left">1858</td><td align="left"/><td align="left">850-3900 - cells/uL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     MONOCYTES</td><td align="left">9.9</td><td align="left"/><td align="left"> - %</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     ABSOLUTE MONOCYTES</td><td align="left">564</td><td align="left"/><td align="left">200-950 - cells/uL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     EOSINOPHILS</td><td align="left">1.2</td><td align="left"/><td align="left"> - %</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     ABSOLUTE EOSINOPHILS</td><td align="left">68</td><td align="left"/><td align="left">15-500 - cells/uL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     BASOPHILS</td><td align="left">0.5</td><td align="left"/><td align="left"> - %</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     ABSOLUTE BASOPHILS</td><td align="left">29</td><td align="left"/><td align="left">0-200 - cells/uL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     MPV</td><td align="left">10.0</td><td align="left"/><td align="left">7.5-12.5 - fL</td></tr></tbody></table></li></ul>     <span class="Underline">LAB: COMPREHENSIVE METABOLIC PANEL (10231) (Collection Date &amp; Time - 07/24/2024 12:40 PM)</span><ul><li><table width="100%" border="0"><tbody><tr><td align="left">          <span class="Underline"/></td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">     </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">     GLUCOSE</td><td align="left">93</td><td align="left"/><td align="left">65-99 - mg/dL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     UREA NITROGEN (BUN)</td><td align="left">18</td><td align="left"/><td align="left">7-25 - mg/dL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     CREATININE</td><td align="left">1.26</td><td align="left">H</td><td align="left">0.50-1.03 - mg/dL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     BUN/CREATININE RATIO</td><td align="left">14</td><td align="left"/><td align="left">6-22 - (calc)</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     SODIUM</td><td align="left">140</td><td align="left"/><td align="left">135-146 - mmol/L</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     POTASSIUM</td><td align="left">4.6</td><td align="left"/><td align="left">3.5-5.3 - mmol/L</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     CHLORIDE</td><td align="left">99</td><td align="left"/><td align="left">98-110 - mmol/L</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     CARBON DIOXIDE</td><td align="left">26</td><td align="left"/><td align="left">20-32 - mmol/L</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     CALCIUM</td><td align="left">9.7</td><td align="left"/><td align="left">8.6-10.4 - mg/dL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     PROTEIN, TOTAL</td><td align="left">7.8</td><td align="left"/><td align="left">6.1-8.1 - g/dL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     ALBUMIN</td><td align="left">4.2</td><td align="left"/><td align="left">3.6-5.1 - g/dL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     GLOBULIN</td><td align="left">3.6</td><td align="left"/><td align="left">1.9-3.7 - g/dL (calc)</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     ALBUMIN/GLOBULIN RATIO</td><td align="left">1.2</td><td align="left"/><td align="left">1.0-2.5 - (calc)</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     BILIRUBIN, TOTAL</td><td align="left">0.6</td><td align="left"/><td align="left">0.2-1.2 - mg/dL</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     ALKALINE PHOSPHATASE</td><td align="left">66</td><td align="left"/><td align="left">37-153 - U/L</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     AST</td><td align="left">12</td><td align="left"/><td align="left">10-35 - U/L</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     ALT</td><td align="left">15</td><td align="left"/><td align="left">6-29 - U/L</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0"><tbody><tr><td align="left">     EGFR</td><td align="left">49</td><td align="left">L</td><td align="left">&gt; OR = 60 - mL/min/1.73m2</td></tr></tbody></table></li></ul><br/>Notes: controlled on low fat diet and comorbid with depression and RA  </td></tr><tr><td/></tr><tr><td><span class="bold">3. Sedative, hypnotic or anxiolytic dependence, uncomplicated</span> <br/>Notes: Diazepam for anxiety.  Pt noted to be dependent on diazepam. unable to wean without return of symptoms. has shown drug seeking behavior for sedative. has shown desire to increase dose of sedative beyond recommended despite recommendation to stay at current dose. has been annoyed by doctor, medical personnel and family to decrease or stop use of sedative.    </td></tr><tr><td/></tr><tr><td><span class="bold">4. Opioid dependence, uncomplicated</span> <br/>Notes: patient using oxycodone for chronic pain and anxiety .pt has shown dependence on codeine syrup. has failed to wean from opiate despite attempts to in the past. has shown drug seeking behavior for opiate and has been annoyed by doctors/medical personnel and family to decrease or stop dependence on opiate. has increased use of opiate beyond recommended dose given by medical personnel   </td></tr><tr><td/></tr><tr><td><span class="bold">5. Chronic obstructive pulmonary disease, unspecified</span> <br/>Notes: controlled on <span class="content_span">   </span><span class="content_span">Ipratropium-Albuterol</span>  </td></tr><tr><td/></tr><tr><td><span class="bold">6. Rheumatoid arthritis, unspecified</span> <br/>Notes: controlled on sulfasalazine  </td></tr><tr><td/></tr><tr><td><span class="bold">7. Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene</span> <br/>     <span class="Underline">LAB: PTH, INTACT WITHOUT CALCIUM (35202) (Collection Date &amp; Time - 07/24/2024 12:40 PM)</span><ul><li><table width="100%" border="0"><tbody><tr><td align="left">          <span class="Underline"/></td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">     </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">     PARATHYROID HORMONE,</td><td align="left">75</td><td align="left"/><td align="left">16-77 - pg/mL</td></tr></tbody></table></li></ul><br/>Notes: dm cotnrolled on lowcarb diet and unable to take dm meds due to hypoglycemia since weight loss after son died and pad due to dm controlle donincreased walking eercises  </td></tr><tr><td/></tr><tr><td><span class="bold">8. Bipolar 1 disorder, depressed, severe</span> <br/>Start ARIPiprazole Tablet, 5 MG, 1 tablet, Orally, Once a day, 90 days, 90 Tablet, Refills 3; Start traMADol HCl Tablet, 50 MG, 1 tablet as needed, Orally, Once a day, 30 days, 30 Tablet, Refills 0.  <br/>Notes: not controlled on cymbalta and amitryptilline. add abilify and refer to dr latif for psych  </td></tr><tr><td/></tr><tr><td><span class="bold">9. Immunodeficiency due to drugs</span> <br/>Notes: due to chronic sulfasalazine for rheumatoid arthritis. contoleld on mask wearing and vaccination every 6 months   </td></tr><tr><td/></tr><tr><td><span class="bold">10. Sacroiliitis, not elsewhere classified</span> <br/>Notes: xray visible inflammation. tender in the right costal and si joint area, treated with sulfasalazine and NSAIDs PRN.   </td></tr><tr><td/></tr><tr><td><span class="bold">11. Supraventricular tachycardia, unspecified</span> <br/>Notes: controlled on maxzide  </td></tr><tr><td/></tr><tr><td><span class="bold">12. Severe persistent asthma, uncomplicated</span> <br/>Notes: controlled on symbicort  </td></tr><tr><td/></tr><tr><td><span class="bold">13. Monoplegia of lower limb following cerebral infarction affecting right non-dominant side</span> <br/>Notes: controlled on walking exercises  </td></tr><tr><td/></tr><tr><td><span class="bold">14. Chronic diastolic (congestive) heart failure</span> <br/>Notes: controlle don maxzide  </td></tr><tr><td/></tr><tr><td><span class="bold">15. Secondary hyperparathyroidism of renal origin</span> <br/>Notes: controlled on increased fluid intake  </td></tr><tr><td/></tr><tr><td><span class="bold">16. Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</span> <br/>Notes: htn controlled on maxzide and chf and ckd due to htn controlled on maxzide and increased fluid intake  </td></tr><tr><td/></tr><tr><td><span class="bold">17. Others </span> <br/>Start Triamcinolone Acetonide Cream, 0.1 %, 1 application, Externally, twice per dy, 30 days, 1 each, Refills 3; Refill Zolpidem Tartrate Tablet, 10 MG, 1 tablet at bedtime as needed, Orally, Once a day, 90 days, 90 Tablet, Refills 2; Refill diazePAM Tablet, 10 MG, 1 tablet as needed, Orally, Once a day, 90 days, 90 Tablet, Refills 2.  <br/>Notes: controlled on cymbalta and amitryptilline.     managed with  <span class="content_span">Triamterene-HCTZ</span> managed RA with sulfasalazine controlle don increased flud intake  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 3074F SYST BP LT 130 MM HG, 3079F DIAST BP 80-89 MM HG, 3008F BODY MASS INDEX DOCD, 1111F DSCHRG MED/CURRENT MED MERGE, 3017F COLORECTAL CA SCREEN DOC REV, 3014F SCREEN MAMMO DOC REV, 2022F DIL RETINA EXAM INTERP REV, 1111F DSCHRG MED/CURRENT MED MERGE</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 2 Months</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99213 Office Visit, Est Pt., Level 3.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>3074F SYST BP LT 130 MM HG. <br/>3079F DIAST BP 80-89 MM HG. <br/>3008F BODY MASS INDEX DOCD. <br/>1111F DSCHRG MED/CURRENT MED MERGE. <br/>3017F COLORECTAL CA SCREEN DOC REV. <br/>3014F SCREEN MAMMO DOC REV. <br/>2022F DIL RETINA EXAM INTERP REV. <br/>1111F DSCHRG MED/CURRENT MED MERGE. </td></tr></tbody></table></li></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by JASON HAFFIZULLA , MD  on 07/25/2024 at 06:49 PM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> Jason Haffizulla, MD</td><td align="right"><span class="bold">Date: </span>07/24/2024</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id11" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="15">General Examination</td><td>General appearance:</td><td colspan="2">morbid obesity</td></tr><tr><td>Head:</td><td colspan="2">normocephalic, atraumatic</td></tr><tr><td>Ears:</td><td colspan="2">normal</td></tr><tr><td>Throat:</td><td colspan="2">clear, no erythema</td></tr><tr><td>Neck / thyroid:</td><td colspan="2">carotid pulses are normal and without bruits, neck is supple, with full range of motion and no cervical lymphadenopathy</td></tr><tr><td>Heart:</td><td colspan="2">regular rate and rhythm without murmurs, gallops, clicks or rubs, S1 and S2 are normal and no S3 and S4 gallop</td></tr><tr><td>Chest:</td><td colspan="2">chest wall with no costochondral junction tenderness, no rib deformity and normal shape and expansion</td></tr><tr><td>Lungs:</td><td colspan="2">clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes</td></tr><tr><td>Abdomen:</td><td colspan="2">tender in the right costal margin with abdominal hernia</td></tr><tr><td>Neurologic:</td><td colspan="2">nonfocal, alert and oriented, depressed bipolar deep tendon reflexes, right sided monoplegia of lower limb due to CVA</td></tr><tr><td>Skin:</td><td colspan="2">skin is warm and dry, with no rashes, good skin turgor and normal hair distribution</td></tr><tr><td>Peripheral pulses:</td><td colspan="2">decreased BLE pulses</td></tr><tr><td>Musculoskeletal:</td><td colspan="2">monoplegia right lower extremity due to CVA, r si joint pain</td></tr><tr><td>Lymph nodes:</td><td colspan="2">no axillary, supraclavicular or inguinal lymphadenopathy</td></tr><tr><td>Oral cavity:</td><td colspan="2">normal, with good dentition</td></tr></tbody></table><br/></li></ul></div><br/><br/></body></html>